Enochian Biosciences, Inc. announced that a potential cure for HIV, developed by pioneering research scientist Dr. Serhat Gumrukçu, Director of the Seraph Research Institute, and his team have successfully completed the Pre-Investigational New Drug process for the U.S. Food and Drug Administration Center for Biologics Evaluation and Research. The submission to the FDA was based on promising results achieved by a 54-year-old man living with HIV, who was unable to sustain HIV viral load suppression with antiviral therapy. Once the patient stopped taking ART, and began using the new innovative SRI treatment, his HIV infection blood levels were controlled more effectively for 365 consecutive days.